# Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries

> **NCT05674565** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Zagazig University** · enrollment: 336 (estimated)

## Conditions studied

- Premature Birth
- NEUROPROTECTION
- MAGNESIUM SULPHATE
- Cerebral Palsy
- Neonatal Death

## Interventions

- **DRUG:** Magnesium sulfate loading with maintenance dose
- **DRUG:** Magnesium sulfate loading dose only

## Key facts

- **NCT ID:** NCT05674565
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-20
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-15
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674565, "Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05674565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*